Stocks and Investing
Stocks and Investing
Fri, May 10, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Nierengarten Reiterated (VOR) at Buy and Held Target at $11 on, May 10th, 2024
David Nierengarten of Wedbush, Reiterated "Vor Biopharma Inc." (VOR) at Buy and Held Target at $11 on, May 10th, 2024.
David has made no other calls on VOR in the last 4 months.
There are 4 other peers that have a rating on VOR. Out of the 4 peers that are also analyzing VOR, 0 agree with David's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with David
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Friday, March 22nd, 2024
- Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $12 on, Thursday, March 21st, 2024
- Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $18 on, Thursday, March 21st, 2024
- Matthew Biegler of "Oppenheimer" Reiterated at Buy with Decreased Target to $15 on, Thursday, March 21st, 2024
Contributing Sources